Cited by 23Muscle Physiology and DisordersNutrition and Health in AgingNuts composition and effects

Nutraceutical Properties of Chestnut Flours: Beneficial Effects on Skeletal Muscle Atrophy

Open access
Frati, Alessia, Landi, Debora, Marinelli, Cristian, Gianni, Giacomo, Fontana, Lucia, Migliorini, Marzia, Pierucci, Federica, Garcia-Gil, Mercedes +1 more·2014·Food Funct.

Abstract

Plants contain a wide range of non-nutritive phytochemicals, many of which have protective or preventive properties for human diseases. The aim of the present work has been to investigate the nutraceutical properties of sweet chestnut flour extracts obtained from fruits collected from 7 geographic areas of Tuscany (Italy), and their ability in modulating skeletal muscle atrophy. We found that the cultivars from different geographic areas are characterized by the composition and quantity of various nutrients and specific bioactive components, such as tocopherols, polyphenols and sphingolipids. The nutraceutical properties of chestnut sweet flours have been evaluated in C2C12 myotubes induced to atrophy by serum deprivation or dexamethasone. We found that the pretreatment with both total extracts of tocopherols and sphingolipids is able to counterbalance cell atrophy, reducing the decrease in myotube size and myonuclei number, and attenuating protein degradation and the increase in expression of MAFbx/atrogin-1 (a muscle-specific atrophy marker). By contrast, polyphenol extracts were not able to prevent atrophy. Since we also found that γ-tocopherol is the major form of tocopherol in sweet flour and its content differs depending on the procedure of sweet flour preparation, the mechanisms by which γ-tocopherol as well as sphingolipids affect skeletal muscle cell atrophy have been also investigated. This is the first evidence that chestnut sweet flour is a natural source of specific bioactive components with a relevant role in the prevention of cell degeneration and maintenance of skeletal muscle mass, opening important implications in designing appropriate nutritional therapeutic approaches to skeletal muscle atrophy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/c4fo00353e

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chestnut flours extracts inhibit the expression of MAFbx in C2C12 myotubes muscle atrophy induced by dexamethasone.

    “For example, chestnut flours extracts, characterized by the composition and quantity of various nutrients and specific bioactive components, such as tocopherols, polyphenols, and sphingolipids, inhibit the expression of MAFbx in C2C12 myotubes muscle atrophy induced by dexamethasone [105].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. E. Meacci, F. Bini and C. Battistini, S1P Signaling in Skeletal Muscle Cells, Methods Mol. Biol., 2012, 874, 155-165.

Cited by

Sorted by citations

Authors
Frati, A., Landi, D., Marinelli, C., Gianni, G., Fontana, L., Migliorini, M., Pierucci, F., Garcia-Gil, M., & Meacci, E.
Affiliations
  • University of Florence (IT)
  • Camera di Commercio di Firenze (IT)
Corresponding author
Meacci, Elisabetta
Venue
Food Funct.
Published
2014-09-03
Volume
5
Issue
11
Pages
2870-2882
ISSN
  • 2042-6496 (ISSN-L)
  • 2042-650X
OpenAlex
W2141914619
Cited by
23
References
47
Citations by year
2025: 4 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 1 · 2015: 1
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Food & Function (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
  • Florence Research (University of Florence) (submittedVersion)
Funders
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Regione Toscana
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Nuts composition and effects
Keywords
chestnut flour, nutraceuticals, skeletal muscle atrophy, gamma-tocopherol, tocopherols, sphingolipids, polyphenols, atrogin-1/MAFbx, myotube atrophy, dexamethasone-induced atrophy, serum deprivation, C2C12 myotubes, bioactive compounds, chestnut cultivars, Tuscany
MeSH terms
Animals, Cell Line, Dexamethasone, Flour, Italy, Muscular Atrophy, Plant Extracts, Sphingolipids, Muscle, Skeletal, Muscle Fibers, Skeletal, Dietary Supplements, Tocopherols, Fagaceae, Mice, Proteolysis, Polyphenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review